Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin for bone metabolism in hypercholesterolemia with low bone mass
KCT0004114Phase 4Not yet recruiting
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pitavastatin in hypercholesterolemia, osteopenia, osteoporosis, sponsored by JW Pharmaceutical Corporation. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemiaosteopeniaosteoporosis
Beyond the preview
Go deeper on KCT0004114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004114.